Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa

Journal of Antimicrobial Chemotherapy - Tập 63 Số 1 - Trang 11-16 - 2009
Joanna C. Evans1, Michael C. Stead1, Mark P. Nicol1, Heidi Segal1,2
1Division of Medical Microbiology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
2Division of Medical Microbiology, National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa

Tóm tắt

Từ khóa


Tài liệu tham khảo

2007, The Global MDR-TB & XDR-TB Response Plan 2007–2008

Ormerod, 2005, Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment, Br Med Bull, 73-74, 17, 10.1093/bmb/ldh047

Gillespie, 2002, Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective, Antimicrob Agents Chemother, 46, 267, 10.1128/AAC.46.2.267-274.2002

Ramaswamy, 1998, Molecular genetic basis of antimicrobial resistance in Mycobacterium tuberculosis: 1998 update, Tuber Lung Dis, 79, 3, 10.1054/tuld.1998.0002

Cavusoglu, 2006, Evaluation of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates, J Clin Microbiol, 44, 2338, 10.1128/JCM.00425-06

Huitric, 2006, Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants, Antimicrob Agents Chemother, 50, 2860, 10.1128/AAC.00303-06

Rigouts, 2007, Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis, J Clin Microbiol, 45, 252, 10.1128/JCM.01489-06

Hazbón, 2006, Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis, Antimicrob Agents Chemother, 50, 2640, 10.1128/AAC.00112-06

Yu, 2003, Reduced affinity for isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance, J Biol Chem, 278, 14769, 10.1074/jbc.M300326200

Hillemann, 2007, Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis isolates and clinical specimens, J Clin Microbiol, 45, 2635, 10.1128/JCM.00521-07

Barnard, 2008, Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa, Am J Respir Crit Care Med, 177, 787, 10.1164/rccm.200709-1436OC

Mokrousov, 2002, Detection of isoniazid-resistant Mycobacterium tuberculosis isolates by a multiplex allele-specific PCR assay targeting katG codon 315 variation, J Clin Microbiol, 40, 2509, 10.1128/JCM.40.7.2509-2512.2002

Leung, 2006, Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA, Antimicrob Agents Chemother, 50, 1075, 10.1128/AAC.50.3.1075-1078.2006

De Wit, 1990, Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification, J Clin Microbiol, 28, 2437, 10.1128/JCM.28.11.2437-2441.1990

National Committee for Clinical Laboratory Standards, 2003, Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes: Approved Standard M24-A

van Soolingen, 1991, Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex isolates: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis, J Clin Microbiol, 29, 2578, 10.1128/JCM.29.11.2578-2586.1991

Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res, 25, 3389, 10.1093/nar/25.17.3389

Kamerbeek, 1997, Simultaneous detection and isolate differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, 35, 907, 10.1128/JCM.35.4.907-914.1997

Filliol, 2002, Global distribution of Mycobacterium tuberculosis spoligotypes, Emerg Infect Dis, 8, 1347, 10.3201/eid0811.020125

Victor, 2004, Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype, J Clin Microbiol, 42, 769, 10.1128/JCM.42.2.769-772.2004

Supply, 2001, Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units, J Clin Microbiol, 39, 3563, 10.1128/JCM.39.10.3563-3571.2001

Miotto, 2006, Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates isolated in Italy, J Clin Microbiol, 44, 2485, 10.1128/JCM.00083-06

Marais, 2006, Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape province of South Africa, J Clin Microbiol, 44, 3539, 10.1128/JCM.01291-06

Aktas, 2005, Molecular characterisation of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey, Microb Drug Resist, 11, 94, 10.1089/mdr.2005.11.94

Marttila, 1996, katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients, Antimicrob Agents Chemother, 40, 2187, 10.1128/AAC.40.9.2187

Heep, 2001, Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates, J Clin Microbiol, 39, 107, 10.1128/JCM.39.1.107-110.2001

Yue, 2003, Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China, J Clin Microbiol, 41, 2209, 10.1128/JCM.41.5.2209-2212.2003

Gagneux, 2006, The competitive cost of antibiotic resistance in Mycobacterium tuberculosis, Science, 312, 1944, 10.1126/science.1124410

Ma, 2006, rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China, J Clin Microbiol, 44, 3409, 10.1128/JCM.00515-06